Shares of Foghorn Therapeutics Inc. fell more than 3% on Monday afternoon, after hitting intraday lows last seen over 10 ...

President-elect Donald Trump said Monday that “I don’t like” school vaccine mandates and that “brilliant people” are ...

President-elect Donald Trump said he plans to “knock out” drug-industry middlemen, a sign the sector isn’t likely to see ...

Powerful weight-loss drugs are expanding use of U.S. health care as patients starting prescriptions are diagnosed with ...

The $16.5 billion take-private deal can now be completed, and along with it Novo Nordisk’s related acquisition of three ...

After clearing all regulatory hurdles associated with its proposed buyout of CDMO Catalent, Novo Holdings is nearly ready to ...

Investors' focus could, however, shift back onto the possible market impacts of GLP-1 agonists in 2025, particularly as a result of a major expansion of current supplies after Novo Nordisk was given a ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 496.78% and ...

Pfizer's shares have significantly underperformed, but the current valuation and high dividend yield present a compelling ...

Weight loss drugs, compounding, vitamin D, and AI all piqued readers’ interest — and sometimes, ire — this past year.

Ratings for the No. 2 and No. 3 cable news networks have plummeted since Donald Trump's victory, while Fox News remains the leader. These companies largely earn their competitive advantage from ...

Dow, S&P 500, and Nasdaq futures are all rising in premarket trading Monday as the stock market braces itself for the Fed's rate decision this week.